Clinical Findings, Elimination Pharmacokinetics, and Tissue Drug Concentrations Following a Fatal Amitriptyline Intoxication
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 18 (1), 119-125
- https://doi.org/10.3109/15563658108990017
Abstract
Following a serious intoxication with amitriptyline [AMI, an antidepressant], clinical features included deep to moderate coma, respiratory depression, hyperreflexia, sinus tachycardia and a widened QRS interval. Initial plasma levels of AMI and nortriptyline (NOR) were 1070 and 410 ng/ml, respectively. Elimination kinetic measurements indicated a normal plasma half-life of 29.5 h for AMI, and a prolonged elevation of plasma NOR concentrations (about 400 ng/ml) with apparent accumulation. This latter result differed markedly from reported NOR elimination kinetics which have been similar to AMI following low dosage. Postmortem analyses indicated a high degree of tissue binding by both drugs. Various organ concentrations of AMI and NOR ranged to about 15 times the plasma concentrations, while in the central nervous system these ratios approached 35- and 45-fold, respectively. Observation of plasma NOR levels provides a salient indication of the progress of detoxication, and emphasizes the necessity for continued close attention to the maintenance of adequate respiration following massive tricyclic antidepressant overdose when systemic drug levels remained elevated.This publication has 18 references indexed in Scilit:
- Monitoring Tricyclic Antidepressant Plasma ConcentrationsPublished by American Medical Association (AMA) ,1979
- Cardiac Rhythm in Tricyclic Antidepressant PoisoningClinical Toxicology, 1979
- Tricyclic AntidepressantsNew England Journal of Medicine, 1978
- Tricyclic AntidepressantsNew England Journal of Medicine, 1978
- Tricyclic antidepressants: plasma levels and clinical findings in overdoseAmerican Journal of Psychiatry, 1978
- Tricyclic Antidepressant OverdoseJAMA, 1977
- Tricyclic antidepressant plasma levels and adverse effects after overdoseClinical Pharmacology & Therapeutics, 1977
- Tricyclic antidepressant overdose: Clinical presentation and plasma levelsClinical Pharmacology & Therapeutics, 1975
- Physostigmine Salicylate in the Treatment of Tricyclic Antidepressant OverdosagePublished by American Medical Association (AMA) ,1975
- Acute Poisoning by Tricyclic Antidepressants: Clinical Features and Management of 100 PatientsClinical Toxicology, 1969